Center Volume and Post-Transplant Survival Among Adults with Congenital Heart Disease

Eighty five percent of congenital heart disease patients currently survive to adulthood due primarily to advancements in surgical treatments1. For these survivors with Adult Congenital Heart Disease (ACHD), heart failure (HF) remains the leading cause of death2. Thus, the number of ACHD patients requiring heart transplantation (HT) continues to grow, and with this growth has come improvements in outcomes. In 2009, Lamour et al. demonstrated a 1-year survival of 83% for non-Fontan congenital HT and 71% for patients with Fontan palliation3.

Source: The Journal of Heart and Lung Transplantation - July 15, 2018 Category: Transplant Surgery Authors: J.N. Menachem, J. Lindenfeld, K. Schlendorf, A.S. Shah, D.P. Bichell, W. Book, D. Brinkley, M. Danter, B. Frischhertz, M. Keebler, B. Kogon, B. Mettler, J. Rossano, S. Brown Sacks, T. Young, M. Wigger, S. Zalawadiya Tags: Original Clinical Science Source Type: research